Beat-to-Beat Blood Pressure Reveals Hidden Autonomic Dysfunction in Sleep Apnea Patients

Obstructive sleep apnea is well-established as a driver of cardiovascular risk, but most clinical assessments focus on nighttime respiratory events rather than daytime autonomic function. This pilot study from the Federal University of São Paulo sought to fill that gap by applying a comprehensive autonomic testing battery to patients undergoing polysomnography for suspected OSA, using continuous non-invasive beat-to-beat blood pressure monitoring via Finapres NOVA photoplethysmography alongside electrocardiography and respiratory effort belts.

Seventeen patients were enrolled between February and March 2020 before the study was halted by COVID-19. The cohort was predominantly male (70.6%), with a mean age of 52 years and a remarkably long mean disease duration of 14 years. Ten patients had moderate OSA and seven had severe OSA, with a mean apnea-hypopnea index of 39.3 events/hour. Hypertension was present in 47% and obesity in 52.9%, reflecting the typical comorbidity burden of this population. Importantly, all participants were untreated for OSA at the time of testing.

Autonomic testing included 6Hz deep breathing to assess cardiovagal parasympathetic function, a 15-second Valsalva maneuver at 40 mmHg to evaluate both adrenergic and cardiovagal responses, and a 5-minute active standing test to probe orthostatic adrenergic regulation. Results were quantified using the QASAT grading scale. The adrenergic sympathetic overactivity subscore averaged 1.0 ± 0.7 (scale 0–2), while the cardiovagal failure subscore averaged 0.41 ± 0.6 (scale 0–3). Fourteen of 17 patients (88.2%) demonstrated adrenergic sympathetic overactivity — 10 via supine hypertension and 4 via orthostatic hypertension (upright SBP exceeding 120% of supine baseline).

Cardiovagal abnormalities were also prevalent. Heart rate responses to deep breathing were abnormal in 6 patients (35.2%), and 9 patients (52.9%) had an abnormal Valsalva ratio (mean 1.44 ± 0.31). Seven patients (41.1%) showed a flat-top Valsalva variant, indicating absent mean blood pressure drop during straining — a pattern associated with elevated sympathetic tone and elevated baseline BP. Only one patient showed adrenergic failure with orthostatic hypotension. Notably, no significant differences in autonomic findings were found between moderate and severe OSA groups, nor between hypertensive and normotensive subgroups for cardiovagal measures.

The clinical implications are meaningful. These findings demonstrate that OSA-related autonomic dysfunction persists into waking hours and is detectable with standardized non-invasive tools already used in autonomic neurology clinics. The orthostatic hypertension finding is particularly relevant given emerging consensus that exaggerated pressor responses to standing carry independent cardiovascular risk. The authors argue that combining polysomnography with daytime autonomic testing — including beat-to-beat BP monitoring — could improve risk stratification for OSA patients beyond AHI alone. However, the small sample size, absence of a control group, and early termination due to COVID-19 limit the generalizability of these findings, and QASAT has not yet been validated in sleep disorder populations.